Articles From: GE’s Water Business to Acquire UK-Based Monsal; Expands Wastewater Offering and Provides Capabilities to Generate Renewable Energy from Biosolids and Biowaste to General Dynamics Awarded $25 Million by Lockheed Martin for Continued Work on U.S. Air Force GPS III Program


2014/7/1
GE (NYSE:GE) today announced that it has agreed to acquire Monsal , a private U.K.-based water, waste, advanced anaerobic digestion and integrated biogas-to-energy business.
Sign-up for GE’s Water Business to Acquire UK-Based Monsal; Expands Wastewater Offering and Provides Capabilities to Generate Renewable Energy from Biosolids and Biowaste investment picks
GECU is bringing convenient, intuitive, and easy-to-use services across both its digital and physical channels through the innovative technology of NCR Corporation (NYSE: NCR), the global leader in consumer transaction technologies.
Sign-up for GECU Selects NCR for Digital and Physical Banking Experiences investment picks
Revenue increases 6% in the second quarter to $23.4 million FAIRFAX, Va.
Sign-up for Geeknet Announces Second Quarter 2014 Financial Results and Acquisition of Treehouse Brand Stores investment picks
FAIRFAX, Va.
Sign-up for Geeknet Sets Second Quarter 2014 Financial Release Date investment picks
FLINT, Mich., June 19, 2014 (GLOBE NEWSWIRE) -- GEI Global Energy Corp.
Sign-up for GEI Global Energy Corp. Announces Board Expansion to Include School of Business Dean investment picks
GEI Global Energy Corp.
Sign-up for GEI Global Energy Corp. Announces Partnership for Italy Fuel Cell Deployment investment picks
2014/7/23
Second on the list would be a trip down under to Australia NEW YORK , July 23, 2014 /PRNewswire/ -- It's the dream many Americans have – to travel to another country for a vacation without worrying about the cost.
Sign-up for Gelato, Trevi Fountain, and The Duomo - Italy is the Country Americans Would Choose For a Vacation If Cost Was Not a Factor investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G017910-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/7/8/11G017910/Logo1-1301595338.jpg http://www.marketwire.com/library/MwGo/2014/7/8/11G017910/Images/image-970620362835.jpg Mastix Medica PALM CITY, FL--(Marketwired - July 08, 2014) - GelStat Corporation (PINKSHEETS: GSAC), a company engaged in the research, development, marketing, licensing and branding of innovative Over-the-Counter (OTC) consumer healthcare products, is pleased to announce it has closed the acquisition of Mastix Medica, LLC on July 7, 2014.
Sign-up for GelStat Corporation Acquires Mastix Medica, LLC for Restricted Common Stock investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G020175-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/8/18/11G020175/Logo1-1911970487.jpg PALM CITY, FL--(Marketwired - August 19, 2014) - GelStat Corporation (PINKSHEETS: GSAC), a fully integrated consumer healthcare company engaged in the research, development, marketing and branding of innovative over-the-counter (OTC) consumer healthcare products addressing very large markets, reported results for the period ended June 30, 2014 and is updating shareholders on recent events.
Sign-up for GelStat Corporation Reports Second Quarter Results and Provides Shareholder Update investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G017387-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/6/23/11G017387/Logo1-496295775.jpg PALM CITY, FL--(Marketwired - June 24, 2014) - GelStat Corporation (PINKSHEETS: GSAC), a company engaged in the research, development, marketing and branding of innovative dietary supplements and Over-the-Counter (OTC) consumer healthcare products, is pleased to announce today that it has launched its new weight loss diet aide "Chews 2 Lose Appetite Suppressant Gum" and has signed a distribution agreement with Windmill Health Products.
Sign-up for GelStat Signs Distribution Agreement With Windmill Health Products for the Distribution of "Chews 2 Lose" Appetite Suppressant Gum investment picks
2014/8/8
By William Horobin PARIS --
Sign-up for Gemalto to buy SafeNet for $890 million investment picks
ORLANDO, Fla., Aug.
Sign-up for Gencor Releases Third Quarter Fiscal 2014 Results investment picks
2014/7/9
SACRAMENTO, Calif., July 9, 2014 (GLOBE NEWSWIRE) -- GenCorp Inc. (NYSE:GY) today reported results for the second quarter ended May 31, 2014.
Sign-up for GenCorp Reports 2014 Second Quarter Results investment picks
2014/9/3
SACRAMENTO, Calif., Sept.
Sign-up for GenCorp to Present at Gabelli & Company's 20th Annual Aircraft Supplier Conference investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G021210-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/9/5/11G021210/Gendis_logo-574489985934.JPG WINNIPEG, MB--(Marketwired - September 05, 2014) - Gendis Inc. (TSX: GDS) today announced its financial results for the 2 nd quarter ended July 31, 2014.
Sign-up for Gendis Inc. Announces Second Quarter Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G021201-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/9/5/11G021201/Gendis_logo-574489985934.JPG WINNIPEG, MB--(Marketwired - September 05, 2014) - The Board of Directors of Gendis Inc. (TSX: GDS) has today declared that a regular quarterly dividend of 2.5 cents per share upon the outstanding Common shares in the capital stock of the Corporation be payable October 3, 2014, to shareholders of record as at the close of business on September 19, 2014.
Sign-up for Gendis Inc. Declares Regular Quarterly Dividend investment picks
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the company has submitted a supplemental Biologics License Application (sBLA) for Lucentis ® (ranibizumab injection) to the U.S. Food and Drug Administration (FDA) for the treatment of diabetic retinopathy.
Sign-up for Genentech Submits Supplemental Biologics License Application to FDA for Lucentis Indication in Diabetic Retinopathy investment picks
2014/7/14
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the Phase III coBRIM study met its primary endpoint.
Sign-up for Genentech’s Investigational Medicine Cobimetinib, Used in Combination with Zelboraf® (Vemurafenib), Helped People with Advanced Melanoma Live Significantly Longer Without Their Disease Worsening investment picks
Generac Holdings Inc. ("Generac") (NYSE: GNRC), a leading designer and manufacturer of power generation equipment and other engine powered products, today announced plans to release its second quarter 2014 financial results before the market opens on Thursday, July 31, 2014.
Sign-up for Generac Announces Second Quarter 2014 Earnings Release Date and Conference Call investment picks
Generac Holdings Inc. (NYSE: GNRC) (the “Company”), a leading designer and manufacturer of power generation equipment and other engine powered products, today reported financial results for its second quarter ended June 30, 2014.
Sign-up for Generac Reports Second Quarter 2014 Results investment picks
The Board of Directors of General American Investors Company, Inc., a closed-end investment company listed on the New York Stock Exchange (GAM), declared on its 5.95% cumulative preferred stock, series B, a dividend and distribution of $0.371875 per share payable in cash on September 24, 2014 to holders of record on September 8, 2014.
Sign-up for General American Investors Company: Quarterly Dividend and Distribution on 5.95% Preferred Stock investment picks
General American Investors Company, Inc., a closed-end investment company listed on the New York Stock Exchange (GAM), filed with the U.S. Securities and Exchange Commission (SEC) its Certified Shareholder Report (Form N-CSR) for the six month period ended June 30, 2014.
Sign-up for General American Investors Files Certified Shareholder Report for Period Ended June 30, 2014 investment picks
General Cable Corporation (NYSE: BGC) , announced today that its Board of Directors appointed Mr.
Sign-up for General Cable Announces Board of Directors Appointment investment picks
General Cable Corporation (NYSE: BGC) (the “Company”) today announced it is implementing a restructuring program designed to improve profitability and return on invested capital in each of its three reportable segments.
Sign-up for General Cable Announces Restructuring Program investment picks
General Cable Corporation (NYSE: BGC) (the “Company”) today announced the commencement of an offer to exchange up to $600,000,000 aggregate principal amount of its outstanding 5.750% Senior Notes due 2022 (the “Old Notes”) for the same principal amount of 5.750% Senior Notes due 2022 (the “New Notes” and, together with the Old Notes, the “Notes”), which have been registered under the Securities Act of 1933, as amended (the “Securities Act”). The Old Notes were issued on September 25, 2012 in a transaction exempt from registration under the Securities Act.
Sign-up for General Cable Commences Registered Exchange Offer for Its 5.750% Senior Notes Due 2022 investment picks
General Cable Corporation (NYSE: BGC) (the “Company”) today announced that it has completed its offer (the “Exchange Offer”) to exchange up to $600,000,000 aggregate principal amount of its outstanding 5.750% Senior Notes due 2022 which were issued in a private placement transaction on September 25, 2012 (the “Old Notes”) for a like principal amount of its 5.750% Senior Notes due 2022 which have been registered under the Securities Act of 1933, as amended (the “Exchange Notes”). The Exchange Offer expired at 5:00 p.m., New York City time, on July 17, 2014.
Sign-up for General Cable Completes Exchange Offer investment picks
General Cable Corporation (NYSE: BGC) announced today that its Board of Directors declared a quarterly dividend of $0.18 per share on all outstanding common shares.
Sign-up for General Cable Declares Dividend investment picks
General Cable Corporation (NYSE: BGC) reported today results for the second quarter ended June 27, 2014.
Sign-up for General Cable Reports Second Quarter Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: GE’s Water Business to Acquire UK-Based Monsal; Expands Wastewater Offering and Provides Capabilities to Generate Renewable Energy from Biosolids and Biowaste to General Dynamics Awarded $25 Million by Lockheed Martin for Continued Work on U.S. Air Force GPS III Program
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices